GeraldesRCiccarelliOBarkhofF, et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol2018; 14: 199–213.
5.
KimHJPaulFLana-PeixotoMA, et al. MRI characteristics of neuromyelitis optica spectrum disorder: An international update. Neurology2015; 84: 1165–1173.
6.
WingerchukDMBanwellBBennettJL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology2015; 85: 177–189.
7.
KesslerRAMealyMALevyM.Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm2016; 3(5): e269.
8.
MotamediSOertelFCYadavSK, et al. Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm2020; 7(5): e805.
9.
OertelFCZimmermannHPaulF, et al. Optical coherence tomography in neuromyelitis optica spectrum disorders: Potential advantages for individualized monitoring of progression and therapy. EPMA J2017; 9: 21–33.
10.
KuchlingJPaulF.Visualizing the central nervous system: Imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders. Front Neurol2020; 11: 450.